These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1732707)

  • 1. Hypoglycemic activities of MTP-3631, a novel thiopyranopyrimidine derivative.
    Ogawa H; Kunoh Y; Sugiura T; Nagasaka M
    Life Sci; 1992; 50(5):375-81. PubMed ID: 1732707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidiabetic activity of MTP-3115 in normal and diabetic mice.
    Yen TT; Dininger NB; Broderick CL; Gill AM
    Arch Int Pharmacodyn Ther; 1990; 308():137-48. PubMed ID: 2099133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies on the hypoglycemic effect of 7,8-dihydro-2-(4-methylpiperazinyl)-4-(1-pyrrolidinyl)-6H-thi opyrano [3,2-d] pyrimidine dimaleate (MTP-1307), a novel hypoglycemic agent.
    Kunoh Y; Ogawa H; Nagasaka M; Asai H; Iguchi A; Niki A; Sakamoto N
    Arch Int Pharmacodyn Ther; 1989; 298():276-87. PubMed ID: 2667487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoglycemic activity of MTP-1403 (2-amino-7,8-dihydro-4-piperazinyl-6H-thiopyrano 3,2-d pyrimidine), a new hypoglycemic agent.
    Kunoh Y; Iguchi A; Gotoh M; Nomura T; Shibata M; Sakamoto N
    Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):302-13. PubMed ID: 3521517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective, hypoglycemic agent, with the biguanides.
    Tutwiler GF; Bridi G
    Diabetes; 1978 Aug; 27(8):868-76. PubMed ID: 680413
    [No Abstract]   [Full Text] [Related]  

  • 6. MTP-1307, a novel antidiabetic agent, improves the glucose intolerance of viable yellow obese-diabetic mice.
    Yen TT
    Life Sci; 1987 Nov; 41(21):2349-54. PubMed ID: 3683081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of new hypoglycemic agent 2-piperazinyl-4-methyl-amino-5-methylthieno [2,3-d]pyrimidine dihydrochloride hydrate.
    Fujiwara T; Sakamoto Y; Fukasawa I; Horikoshi H; Sugiyama M; Fukumi H
    Arzneimittelforschung; 1986 Dec; 36(12):1770-4. PubMed ID: 2882759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral antidiabetics on the anaphylactoid reaction.
    Wellinger K; Koltai M
    Acta Physiol Acad Sci Hung; 1981; 58(4):317-9. PubMed ID: 6182744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
    Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
    Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of centpiperalone in combination with biguanide & sulfonylurea.
    Srivastava PP; Murthy PS; Mukherjee SK
    Indian J Exp Biol; 1983 Jul; 21(7):390-2. PubMed ID: 6365752
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of an alpha 2-adrenoceptor antagonist on glucose tolerance in the genetically obese mouse (C57BL/6J ob/ob).
    Saperstein R; Chapin EW; Brady EJ; Slater EE
    Metabolism; 1990 May; 39(5):445-51. PubMed ID: 1970847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral hypoglycemic drugs on heart norepinephrine (NE) in rats and mice.
    Anton AH; Berk AI
    Res Commun Chem Pathol Pharmacol; 1982 Jan; 35(1):79-94. PubMed ID: 7058290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciglitazone, a new hypoglycemic agent. II. Effect on glucose and lipid metabolisms and insulin binding in the adipose tissue of C57BL/6J-ob/ob and -+/? mice.
    Chang AY; Wyse BM; Gilchrist BJ
    Diabetes; 1983 Sep; 32(9):839-45. PubMed ID: 6354791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycemic dipeptide cyclo (His-Pro) significantly altered plasma proteome in streptozocin-induced diabetic rats and genetically-diabetic (ob/ob) mice.
    Choi SA; Yun JW; Park HS; Choi JW
    Mol Biol Rep; 2013 Feb; 40(2):1753-65. PubMed ID: 23086277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacologic profile of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective hypoglycemic agent.
    Tutwiler GF; Kirsch T; Bridi G
    Diabetes; 1978 Aug; 27(8):856-67. PubMed ID: 98377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihyperglycemic effect of equol, a daidzein derivative, in cultured L6 myocytes and ob/ob mice.
    Cheong SH; Furuhashi K; Ito K; Nagaoka M; Yonezawa T; Miura Y; Yagasaki K
    Mol Nutr Food Res; 2014 Feb; 58(2):267-77. PubMed ID: 24039053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihyperglycaemic effect of saccharin in diabetic ob/ob mice.
    Bailey CJ; Day C; Knapper JM; Turner SL; Flatt PR
    Br J Pharmacol; 1997 Jan; 120(1):74-8. PubMed ID: 9117102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin-stimulating properties of Glybenclamide (HB 419) in healthy subjects. Comparative studies with tolbutamide].
    Brunetti P; Cozzolino G; Santeusanio F; Arena D; De Ciuceis P; Marri G; Migliorini E
    Acta Diabetol Lat; 1969; 6(2):283-98. PubMed ID: 5397408
    [No Abstract]   [Full Text] [Related]  

  • 20. Amelioration of insulin resistance in genetically obese rodents by M16209, a new antidiabetic agent.
    Murakami N; Ohta M; Hashimoto K; Kato K; Mizota M; Miwa I; Okuda J; Inoue G; Kuzuya H; Nakao K; Imura H
    Eur J Pharmacol; 1996 May; 304(1-3):129-34. PubMed ID: 8813594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.